Living donor liver transplantation and tolerance: A potential strategy in cholangiocarcinoma

Transplantation

Volumn 76, Issue 6, 2003, Pages 1003-1006

  Kadry, Zakiyah ^a   Mullhaupt, Beat ^a   Renner, Eberhard L ^a   Bauerfeind, Peter ^a   Schanz, Urs ^a   Pestalozzi, Bernhard C ^a   Studer, Gabriella ^a   Zinkernagel, Rolf ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; CASE REPORT; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ADULT; BONE MARROW TRANSPLANTATION; CHOLANGIOCARCINOMA; HUMANS; IMMUNE TOLERANCE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; NEOPLASM INVASIVENESS; NUCLEAR FAMILY; TREATMENT OUTCOME;

EID: 0141544923     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000083981.82522.13     Document Type: Article

References (20)

1. Billingham RE, Brent L, Medawar PB. "Actively acquired tolerance" of foreign cells. Nature 1953; 172: 603-606.
2. Sayegh MH, Fine NA, Smith JL, et al. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 1991; 114: 954-955.
3. Helg C, Chapuis B, Bolle J, et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic BMT. Transplantation 1994; 58: 1420-1422.
4. Buhler LH, Spitzer TR, Sykes M, et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002; 74(10): 1405-1409.
5. Mazariegos GV, Reyes J, Marino IR, et al. Weaning ofimmunosuppression in liver transplant recipients. Transplantation 1997; 63(2): 243-249.
6. Urban Ch, Deutschmann A, Kerbl R, et al. Organ tolerance following cadaveric liver transplantation for chronic graft vs host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2002; 30: 535-537.
7. Starzl TE, Zinkernagel RM. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998; 339(26): 1905-1913.
8. Thiede C, Florek M, Bornhäuser M, et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055-1060.
9. Matthes-Martin S, Peters C, Könisrainer A, et al. Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood 2000; 96(12): 3997-3999.
10. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998; 187(4): 358-364.
11. Nimura Y, Kamiya J, Nagino M, et al. Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1998; 5: 52-61.
12. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110: 726-734.
13. De Vreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000; 6(3): 309-316.
14. Sudan D, DeRoover A, Chinnakotia S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002; 2(8): 774-779.
15. Urego M, Flickinger JC, Carr B. Radiotherapy and multimodality management of cholangiocarcinoma. Int Radiation Oncol Biol Phys 1999; 44: 121-126.
16. Ringe B, Wittekind C, Bechstein WO, et al. The role of liver transplantation in hepatobiliary malignancy: a retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg. 1989; 209(1): 88-98.
17. O'Grady JG. Treatment options for other hepatic malignancies. Liver Transpl 2000; 6(6): S23-S29.
18. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742-747.
19. Freise CE, Ferrell L, Liu T, et al. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation 1999; 67(4): 510-513.
20. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell autonomous mechanism. Nature 1999; 397(6719): 530-534.